Aerovate Therapeutics (AVTE) Earnings Date, Estimates & Call Transcripts $2.75 +0.07 (+2.61%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.74 -0.02 (-0.55%) As of 04/17/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Earnings Summary Upcoming Earnings DateMay. 12Before Market OpensEstimatedConsensus EPS (Mar. 27) -$0.19 Actual EPS (Mar. 27) -$0.19 Aerovate Therapeutics posted Q4 2024 earnings on March 27, 2025, reporting an EPS of -$0.19, which hit analysts' consensus estimates of -$0.19. With a trailing EPS of -$2.44, Aerovate Therapeutics' earnings are expected to grow next year, from ($2.64) to ($0.84) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K)AVTE Upcoming EarningsAerovate Therapeutics' Q4 2024 earnings is scheduled for Monday, May 12, 2025Powered by Get Aerovate Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aerovate Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAVTE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Aerovate Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.41-$0.41-$0.41Q2 20251-$0.31-$0.31-$0.31Q3 20251-$0.25-$0.25-$0.25Q4 20251-$0.17-$0.17-$0.17FY 20254($1.14)($1.14)($1.14) Aerovate Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)--------3/27/2025Q4 2024-$0.19-$0.19--$0.19--11/12/2024--$0.59-$0.56+$0.03-$0.56--8/12/2024Q2 2024-$0.76-$0.86 -$0.10-$0.86--5/13/2024Q1 2024-$0.74-$0.83 -$0.09-$0.83--3/25/2024Q4 2023-$0.68-$0.74 -$0.06-$0.74--11/13/2023Q3 2023-$0.70-$0.71 -$0.01-$0.71--8/14/2023Q2 2023-$0.69-$0.76 -$0.07-$0.76--5/15/2023Q1 2023-$0.58-$0.67 -$0.09-$0.67-- Aerovate Therapeutics Earnings - Frequently Asked Questions When is Aerovate Therapeutics's earnings date? Aerovate Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on AVTE's earnings history. Did Aerovate Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aerovate Therapeutics (NASDAQ:AVTE) reported ($0.19) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.19). Learn more on analysts' earnings estimate vs. AVTE's actual earnings. How much profit does Aerovate Therapeutics generate each year? Aerovate Therapeutics (NASDAQ:AVTE) has a recorded net income of -$75.52 million. AVTE has generated -$2.44 earnings per share over the last four quarters. What is Aerovate Therapeutics's EPS forecast for next year? Aerovate Therapeutics's earnings are expected to grow from ($2.64) per share to ($0.84) per share in the next year. More Earnings Resources from MarketBeat Related Companies Benitec Biopharma Earnings Allogene Therapeutics Earnings Oruka Therapeutics Earnings Alpha Teknova Earnings Entrada Therapeutics Earnings Mereo BioPharma Group Earnings Heron Therapeutics Earnings Cryoport Earnings COMPASS Pathways Earnings Olema Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NASDAQ:AVTE) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
